We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
-10.3%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.85B
AUM Growth
-$949M
Cap. Flow
-$393M
Cap. Flow %
-10.22%
Top 10 Hldgs %
10.07%
Holding
2,323
New
652
Increased
471
Reduced
539
Closed
577

Sector Composition

Rank Sector Weight
1 Technology 15.44%
2 Consumer Discretionary 14.53%
3 Healthcare 13.43%
4 Industrials 13.16%
5 Financials 12.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPHS
1701
DELISTED
Sophiris Bio, Inc.
SPHS
$52K ﹤0.01%
+62,185
New +$122K
AVXL icon
1702
Anavex Life Sciences
AVXL
$310M
$49K ﹤0.01%
+31,400
New +$71.3K
XTIA icon
1703
XTI Aerospace
XTIA
$58.9M
0
QCLS
1704
Q/C Technologies Inc
QCLS
$22.9M
0
ONCT
1705
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$47K ﹤0.01%
+431
New +$86.2K
MTEM
1706
DELISTED
Molecular Templates, Inc.
MTEM
$46K ﹤0.01%
+767
New +$53.5K
SRAX
1707
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$45K ﹤0.01%
+22,161
New +$61.2K
JASN
1708
DELISTED
Jason Industries, Inc.
JASN
$44K ﹤0.01%
+31,798
New +$72.5K
AREX
1709
DELISTED
Approach Resources Inc.
AREX
$43K ﹤0.01%
+49,521
New +$75.8K
AVH
1710
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$42K ﹤0.01%
+10,331
New +$52.3K
TIS
1711
DELISTED
Orchids Paper Products, Inc.
TIS
$41K ﹤0.01%
+43,714
New +$73.8K
CHRN
1712
ChronoScale Holdings
CHRN
$3.04B
$40K ﹤0.01%
+143
New +$61.3K
IBRX icon
1713
ImmunityBio
IBRX
$8.1B
$40K ﹤0.01%
+34,590
New +$79.1K
NRXPW
1714
DELISTED
NRX Pharmaceuticals Warrant
NRXPW
$40K ﹤0.01%
105,000
NEOS
1715
DELISTED
Neos Therapeutics, Inc
NEOS
$40K ﹤0.01%
+24,171
New +$67.8K
TOTAW
1716
DELISTED
Tottenham Acquisition I Limited Warrant
TOTAW
$40K ﹤0.01%
200,000
PAYS icon
1717
Paysign
PAYS
$705M
$39K ﹤0.01%
+11,046
New +$41K
VTGN icon
1718
VistaGen Therapeutics
VTGN
$12.8M
$39K ﹤0.01%
+872
New +$47.5K
CENN icon
1719
Cenntro
CENN
$8.43M
0
FBIO icon
1720
Fortress Biotech
FBIO
$88.7M
$38K ﹤0.01%
+2,911
New +$48.6K
GEVO icon
1721
Gevo
GEVO
$382M
$38K ﹤0.01%
+19,385
New +$59.4K
GLACW
1722
DELISTED
Greenland Acquisition Corporation Warrant
GLACW
$38K ﹤0.01%
190,875
ATEC icon
1723
Alphatec Holdings
ATEC
$1.44B
$35K ﹤0.01%
15,226
-52,866
-78% -$149K
TRPX
1724
DELISTED
Therapix Biosciences Ltd.
TRPX
$35K ﹤0.01%
+10,709
New +$62K
CYPH
1725
Cypherpunk Technologies Inc
CYPH
$73.3M
$32K ﹤0.01%
+1,590
New +$70K

Similar funds

Oxford Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Oxford Asset Management held 2,323 positions worth $3.85B, down 20% from $4.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Oxford Asset Management withdrew a net $393M in Q4 2018, closing 577 positions and reducing 539 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $105M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Oxford Asset Management opened a new position in Athenahealth, Inc. worth $69.9M.

  • Oxford Asset Management's largest Q4 2018 buy was Athenahealth, Inc.: 530,000 shares worth $69.9M.
  • Oxford Asset Management added most to Integrated Device Technology I in Q4 2018, an estimated $34.6M increase.
  • Oxford Asset Management's biggest Q4 2018 reduction was GE Aerospace, cutting an estimated $18.1M.
  • Oxford Asset Management fully exited Envision Healthcare Holdings Inc in Q4 2018, selling an estimated $105M.
  • Oxford Asset Management's ten largest holdings make up 10% of its $3.85B portfolio in Q4 2018.
  • Oxford Asset Management opened 652 new positions and closed 577 in Q4 2018.
  • Oxford Asset Management's portfolio value fell 20% quarter-over-quarter to $3.85B.

Based on Oxford Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.